This inventor holds 1 USPTO granted patent. Top assignees: Cha University Industry-Academic Cooperation Foundation, Ewha University-Industry Collaboration Foundation, Yonsei University. Active years: 2025.
Company Filing History:
1 out of 8 
1 out of 204 
1 out of 1,470 
Years Active: 2025
Title: Hyunji Jo: Innovator in Cancer Treatment
Introduction
Hyunji Jo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on the prevention, amelioration, and treatment of cancer, showcasing his commitment to advancing medical science.
Latest Patents
Hyunji Jo holds a patent for a composition aimed at the prevention, amelioration, or treatment of cancer. The patent describes alpha-beta unsaturated aryl, heteroaryl, and cycloalkylene ketone compounds that are effective in inhibiting the growth of cancer cells. This innovation not only targets cancer cell growth but also inhibits metastasis, making it a crucial development in cancer therapy. He has 1 patent to his name.
Career Highlights
Throughout his career, Hyunji Jo has worked with esteemed institutions, contributing to research and development in cancer treatment. His expertise and dedication have positioned him as a key figure in the scientific community.
Collaborations
Hyunji Jo has collaborated with various organizations, including the Ewha University-Industry Collaboration Foundation and the Cha University Industry-Academic Cooperation Foundation. He has also worked alongside notable colleagues such as Youngjoo Kwon and Soo-Yeon Hwang, who have contributed to his research endeavors.
Conclusion
Hyunji Jo's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions are paving the way for advancements in cancer therapy and improving patient outcomes.